SAWC Spring 2019 Posters

May 27, 2019Press Releases

Research posters sponsored by Next Science were presented at the Symposium on Advanced Wound Care Spring 2019 meeting in San Antonio, TX.

Next Science Lists on Australian Securities Exchange

April 23, 2019Press Releases

SYDNEY, Australia, 18 April 2019 – Following Next Science Limited’s successful $35 million initial public offer (IPO), the company’s shares are scheduled to list on the ASX at 11.00am today.  The company’s ASX ticker code will be NXS. Read the Full Release

Outliers: Reexamining Wounds That Fail to Heal

January 29, 2019Press Releases

Delayed attention or ineffective treatment nurtures biofilm, facilitating its spread even during bacterial eradication modalities and treatments that involve clinic-based debridement, dressings, antiseptics, and antibiotics. “Could part of the problem be biofilm and part of the healing solution be biofilm-directed care?” This article reexamines why wounds fail to heal. Access the full article, one of … Read More

Next Science® Xbio Technology Expands Use into the Operating Room

October 29, 2018Press Releases

Sydney, NSW and Jacksonville, FL: Next Science® is excited to announce the release of its newest product, SurgX™, available in the US market. SurgX™ is an innovative and first of its type, sterile antimicrobial surgical wound gel designed to help reduce superficial surgical site infections (SSIs) through the management and protection of the post-surgical wound … Read More

Next Science® Expands its Board to Support Continued Global Expansion

October 18, 2018Press Releases

Sydney, NSW: Next Science is excited to announce the appointment of Aileen Stockburger and Mark Compton (AM) to the Board of the company as Non-Executive Directors. Both bring a wealth of diverse international healthcare experience to the Board, as the company expands the adoption of its Xbio™ Technology and the product applications globally across wound … Read More

George Savvides Joins Next Science Board of Directors

August 1, 2018Press Releases

Next Science welcomes George Savvides to its board of directors as Independent Chairperson. Mr Savvides is currently on the board of directors of Ryman Healthcare. He serves as the Chairman of both Macquarie University Hospital and Kings Transport Group Ltd, and is the Deputy Chairman of the Australian public broadcaster, SBS. Read the Full Release

New Mayo Clinic Study Demonstrates Effectiveness of BlastX for Treating Chronic Wounds

February 7, 2018Press Releases

Next Science is excited to announce the results of a prospective, randomized 12-week Mayo Clinic study about the use of BlastX antimicrobial wound gel on chronic wounds to determine if disrupting chronic wound biofilm is therapeutically efficacious. The positive results are published in WOUNDS®. The study represents statistically significant findings for both reduction in wound … Read More

Next Science’s XbioTM Technology Shows Potential to Lower Catheter-Associated Urinary Tract Infection Rates

January 26, 2018Press Releases

Next Science is pleased to announce the publication of a comprehensive article about the application of its Xbio technology to help prevent the development of E. coli biofilms on urinary tract catheters, a leading cause in catheter-associated urinary tract infections. The results are published in the Journal of Medical Microbiology & Diagnosis. View Publication Read … Read More